Pioglitazone vs Metformin: Labels and a 1-Year Trial
App Library Tools Pricing Download
[Diabetes · Comparison]

Pioglitazone vs metformin: how do they compare?

Mechanism · Dosing · Warnings · Head-to-head trial

Short answer: Both are tablets for type 2 diabetes. Pioglitazone (Actos) activates PPAR-gamma to make the body more sensitive to insulin; metformin is a biguanide.12 In a 52-week head-to-head trial, HbA1c fell about 1.4% to 1.5% on each, but weight rose 1.9 kg on pioglitazone and fell 2.5 kg on metformin.3 Their boxed warnings differ: heart failure for pioglitazone, lactic acidosis for metformin.

How do pioglitazone and metformin compare side by side?

From the US Actos and metformin tablet labels; trial rows from Schernthaner 2004.
Pioglitazone (Actos)Metformin
Drug classThiazolidinedione; PPAR-gamma agonist1Biguanide2
Approved forBlood sugar control in adults with type 2 diabetes1Blood sugar control in adults and children 10 and older with type 2 diabetes2
Tablets15, 30 and 45 mg1500, 850 and 1,000 mg2
Label dosing (adults)15 or 30 mg once a day, up in 15 mg steps to 45 mg at most1500 mg twice a day or 850 mg once a day with meals, up to 2,550 mg a day in divided doses2
Half-life3 to 7 hours; active metabolites 16 to 24 hours1About 6.2 hours in plasma, 17.6 hours in whole blood2
Boxed warningCan cause or worsen heart failure; not started in NYHA class III or IV heart failure1Lactic acidosis2
Most common side effects (5% or more)Upper respiratory infection, headache, sinusitis, muscle pain, sore throat1Diarrhea, nausea or vomiting, gas, weakness, indigestion, stomach discomfort, headache2
Head-to-head: HbA1c, 52 weeksAbout −1.4% to −1.5% in both groups3About −1.4% to −1.5% in both groups3
Head-to-head: weight+1.9 kg3−2.5 kg3
Head-to-head: fasting glucose−45.0 mg/dL3−39.6 mg/dL3

Reviewed . Half-life figures are shown only where the value Dose Track uses agrees with the cited source.

What did the head-to-head trial find?

Schernthaner and colleagues randomized 1,199 people with type 2 diabetes who were not on diabetes medicine to pioglitazone (up to 45 mg a day) or metformin (up to 850 mg three times a day) for 52 weeks, double blind.3

  • HbA1c fell by a similar amount in both groups (1.4% and 1.5%).3
  • Fasting glucose fell more on pioglitazone (−45.0 vs −39.6 mg/dL).3
  • Triglycerides and HDL improved more on pioglitazone; LDL and total cholesterol rose on pioglitazone.3
  • Urine albumin fell 19% on pioglitazone and was unchanged on metformin (−1%).3
  • Weight went up 1.9 kg on pioglitazone and down 2.5 kg on metformin.3

The overall rate of side effects was similar, but the kinds of side effects differed.3

How do the label warnings differ?

  • Pioglitazone: heart failure (boxed), fluid retention and dose-related weight gain, more bone fractures in women (5.1% vs 2.5% on placebo in the PROactive trial), and a possible higher risk of bladder cancer (0.54% vs 0.19% diagnosed in PROactive, with observational studies disagreeing).1
  • Metformin: lactic acidosis (boxed), with risk factors including kidney problems, age 65 or older, contrast dye, surgery and heavy drinking. It can also lower vitamin B12, and the label suggests checking B12 every 2 to 3 years.2

More detail: metformin side effects, the metformin dosing schedule, and the Pioglitazone and Metformin guides.

Metformin vs Jardiance: how do the two diabetes tablets differ?Biguanide vs SGLT2 tablet, plus the combination trial Metformin vs Ozempic: how do they differ?Generic daily tablet vs weekly GLP-1 pen Jardiance vs Januvia: how do the two diabetes tablets differ?Sugar out in the urine vs longer-lasting gut hormones Rapamycin vs metformin: what does the aging research show?Two off-label longevity drugs, mostly mouse data

Frequently asked questions

Does pioglitazone cause weight gain?+
The Actos label says dose-related weight gain occurs, probably from fluid retention and fat gain. In the 52-week trial against metformin, weight rose 1.9 kg on pioglitazone and fell 2.5 kg on metformin.13
Is pioglitazone as effective as metformin for HbA1c?+
In a 52-week head-to-head trial of 1,199 people, HbA1c fell by a similar amount on each (1.4% and 1.5%).3
Who should not start pioglitazone?+
The label says not to start it in people with NYHA class III or IV heart failure, and to limit the first dose to 15 mg with class I or II. It is not used with active bladder cancer.1
What is the main warning for metformin?+
Lactic acidosis, a rare but serious build-up of lactic acid. The label lists kidney problems, age 65 or older, contrast dye, surgery and heavy drinking among the risk factors.2
Can I track pioglitazone and metformin in Dose Track?+
Yes. Log each tablet with reminders, including split morning and evening metformin doses.

Sources

  1. Actos (pioglitazone) tablets prescribing information, boxed warning and sections 1, 2, 3, 5, 6.1 and 12.3. DailyMed, version 20 (March 2025).
  2. Metformin hydrochloride tablets (Zydus) prescribing information, boxed warning and sections 1, 2, 3, 5, 6.1, 12.3 and 14. DailyMed, version of July 2026.
  3. Schernthaner G, et al. Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial. J Clin Endocrinol Metab. 2004;89:6068-6076.

All compound comparisons · Pioglitazone guide · Metformin guide · All compound guides · Peptide tracking in Dose Track